Sign in
4/A

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-19-053184

CEO, Pres, CFO, Treas & Secy sold 1,350 shares at $1.70 ($2,295)

From the SEC's structured data for this filing

Trades in this filing

KENYON LAWRENCE A · CEO, Pres, CFO, Treas & Secy

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-09-18 Sale : show line 1 in the form −1,350 $1.70 $2,295 8,926 D
Open-market sales · 1,350 sh · avg $1.70 · $2,295
Loading xslF345X03/doc4a.xml…